ZNF692基因在肾透明细胞癌中的表达及其与患者预后间关系的研究

doi:10.16150/j.1671-2870.2020.03.016

摘要/Abstract

摘要：

目的： 研究ZNF692基因在肾透明细胞癌（clear cell renal cell carcinoma, ccRCC）中的表达特征及其与患者预后间的关系,并分析ZNF692基因相关的调控机制。方法： 采用癌症基因组图谱（The Cancer Genome Atlas, TCGA）数据库进行生物信息数据挖掘,提取516例ccRCC样本,分析ZNF692的表达特征及水平与ccRCC预后之间的关联,进一步分析ZNF692表达水平与DNA拷贝数、甲基化及组蛋白修饰间的关联,探索 ZNF692的上游调控机制。收集本院20例ccRCC患者资料,采用实时定量反转录聚合酶链反应（quantitative reverse transcription polymerase chain reaction, qRT-PCR）检测癌及配对癌旁组织中ZNF692基因的表达水平,分析ZNF692表达与ccRCC患者预后间的关系;敲低ccRCC细胞株786-O 和769-P ZNF692基因后,观察细胞的增殖状态,分析ZNF692的功能。结果： 数据挖掘及临床样本分析提示,相对于癌旁组织,ZNF692在肿瘤组织中高表达（P<0.05）;ZNF692高表达的ccRCC患者总体生存期（Logrank统计分析,P<0.000 1）及无事件生存期（Logrank统计分析,P<0.000 1）低于低表达患者。数据库数据挖掘及临床样本分析提示ZNF692高表达与c-MYC转录激活相关;ZNF692转录调控处于高度转录活化的状态,组蛋白H3赖氨酸27位点乙酰化（H3K27ac）富集;敲低细胞株ZNF692基因后, ccRCC细胞增殖被显著抑制（P<0.05）。结论： ZNF692作为潜在癌基因参与了ccRCC的发生、发展,且其在ccRCC中高表达与患者预后不良相关。

关键词: 肾透明细胞癌, ZNF692基因, 预后, 机制

Abstract:

Objective: To analyze the expression and prognostic value of ZNF692 gene in clear cell renal cell carcinoma (ccRCC) and to explore the related regulation mechanism. Methods: The RNA-Seq and clinical data were extracted from The Cancer Genome Atlas (TCGA) database and the correlation of ZNF692 expression with prognosis in the 516 ccRCC patients obtained were assessed. Twenty paired cancerous and paracancerous tissue samples of ccRCC patients were collected at Ruijin Hospital, and quantitative RT-PCR was used to determine ZNF692 gene expression. Upstream regulation mechanism of ZNF692 gene was explored by analyzing gene expression level with DNA copy number, DNA methylation and histone modification. Cell proliferations in ccRCC cell lines 786-O and 769-P with ZNF692 gene knockdown were detected and the function of ZNF692 gene was analyzed. Results: TCGA data extraction and analysis of the clinical samples revealed that ZNF692 gene was highly expressed in ccRCC cancer tissue compared with paracancerous tissue, and the high level of ZNF692 gene expression predicted a poor prognosis. Patients with high ZNF692 gene expression had shorter overall survival and event-free survival than those with low ZNF692 gene expression. High expression of ZNF692 gene was correlated with activation of c-MYC transcription. In regulatory region of ZNF692 gene, H3K27ac was enriched and in a highly activated transcription state. Knockdown of ZNF692 gene inhibited cell proliferation in ccRCC. Conclusions: ZNF692 as a potential oncogene is involved in the development and progress of ccRCC, and high expression of ZNF692 in ccRCC predicts a poor prognosis

Key words: Clear cell renal cell carcinoma, ZNF692 gene, Prognosis, Mechanism

中图分类号:

R737.11

徐兆平, 王浩飞. ZNF692基因在肾透明细胞癌中的表达及其与患者预后间关系的研究[J]. 诊断学理论与实践, 2020, 19(03): 292-296.

XU Zhaoping, WANG Haofei. Expression of ZNF692 gene in clear cell renal cell carcinoma and its relationship with prognosis[J]. Journal of Diagnostics Concepts & Practice, 2020, 19(03): 292-296.

图/表 4

图1

图2

图3

图4

参考文献 13

[1]	Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1):7-30. doi: 10.3322/caac.21442 URL
[2]	Capitanio U, Montorsi F. Renal cancer[J]. Lancet, 2016, 387(10021):894-906. doi: 10.1016/S0140-6736(15)00046-X pmid: 26318520
[3]	Guo J, Ma J, Sun Y, et al. Chinese guidelines on the management of renal cell carcinoma(2015 edition)[J]. Ann Transl Med, 2015, 3(19):279.
[4]	Cheng J, Zhang J, Han Y, et al. Integrative analysis of histopathological images and genomic data predicts clear cell renal cell carcinoma prognosis[J]. Cancer Res, 2017, 77(21):e91-e100. doi: 10.1158/0008-5472.CAN-17-0313 URL
[5]	Xing Y, Ren S, Ai L, et al. ZNF692 promotes colon adenocarcinoma cell growth and metastasis by activating the PI3K/AKT pathway[J]. Int J Oncol, 2019, 54(5):1691-1703.
[6]	Zhang Q, Zheng X, Sun Q, et al. ZNF692 promotes proliferation and cell mobility in lung adenocarcinoma[J]. Biochem Biophys Res Commun, 2017, 490(4):1189-1196. doi: 10.1016/j.bbrc.2017.06.180 URL
[7]	Huang CC, Gadd S, Breslow N, et al. Predicting relapse in favorable histology Wilms tumor using gene expression analysis: A report from the renal tumor committee of the children's oncology group[J]. Clin Cancer Res, 2009, 15(5):1770-1778. doi: 10.1158/1078-0432.CCR-08-1030 URL
[8]	Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma[J]. Nature, 2013, 499(7456):43-49. doi: 10.1038/nature12222 URL
[9]	Yao X, Tan J, Lim KJ, et al. VHL deficiency drives enhancer activation of oncogenes in clear cell renal cell carcinoma[J]. Cancer Discov, 2017, 7(11):1284-1305. doi: 10.1158/2159-8290.CD-17-0375 URL
[10]	Langmead B, Salzberg SL. Fast gapped-read alignment with bowtie 2[J]. Nat Methods, 2012, 9(4):357-359. doi: 10.1038/nmeth.1923 pmid: 22388286
[11]	Heinz S, Benner C, Spann N, et al. Simple combinations of lineage-determining transcription factors prime cis-re-gulatory elements required for macrophage and B cell identities[J]. Mol Cell, 2010, 38(4):576-589. doi: 10.1016/j.molcel.2010.05.004 pmid: 20513432
[12]	Inoue E, Yamauchi J. AMP-activated protein kinase regu-lates pepck gene expression by direct phosphorylation of a novel zinc finger transcription factor[J]. Biochem Biophys Res Commun, 2006, 351(4):793-799. doi: 10.1016/j.bbrc.2006.10.124 URL
[13]	Shirai T, Inoue E, Ishimi Y, et al. AICAR response element binding protein (AREBP), a key modulator of hepa-tic glucose production regulated by AMPK in vivo[J]. Biochem Biophys Res Commun, 2011, 414(2):287-291. doi: 10.1016/j.bbrc.2011.08.120 URL

[1]	谢吻, 梁怀予, 董磊, 袁菲, 王朝夫, 郭滟. 胰腺导管腺癌重要驱动基因突变与临床病理特征、预后间相关性的分析[J]. 诊断学理论与实践, 2022, 21(05): 581-587.
[2]	陈宏, 沈银忠. 人类免疫缺陷病毒感染/艾滋病合并结核病的诊治进展[J]. 诊断学理论与实践, 2022, 21(04): 530-534.
[3]	汤建平, 龚邦东. 干燥综合征的诊治现状、挑战和思考[J]. 诊断学理论与实践, 2022, 21(03): 291-298.
[4]	李蕾, 袁菲, 王朝夫, 许海敏, 王婷. 101例壶腹部腺癌临床病理及预后因素分析[J]. 诊断学理论与实践, 2022, 21(03): 355-361.
[5]	陈曦, 杜鹃. 多发性骨髓瘤预后风险的精准评估[J]. 诊断学理论与实践, 2021, 20(06): 522-528.
[6]	冯国伟, 张晓娟, 郭睿, 关哲, 王越. 治疗前¹⁸F-FDG PET/CT显像对结外NK/T细胞淋巴瘤的预后判断价值[J]. 诊断学理论与实践, 2021, 20(06): 533-539.
[7]	梁亚丽, 赵海港, 项广宇. 应激性高血糖比值预测急性缺血性脑卒中患者溶栓治疗后1年不良预后的价值[J]. 诊断学理论与实践, 2021, 20(06): 562-566.
[8]	罗雅方, 徐倩玥, 余红. 尘螨在特应性皮炎中的致病机制及相关免疫治疗应用研究进展[J]. 诊断学理论与实践, 2021, 20(06): 592-595.
[9]	苏长青. 从基础研究到临床转化应用谈肝癌的诊治进展[J]. 诊断学理论与实践, 2021, 20(05): 427-433.
[10]	冯明洋, 丁叶舟, 赵青青, 赵钢德, 娄世珂, 郑超, 孙学华, 刘柯慧, 林兰意, 谢青, 郑岚, 王晖. 肝衰竭患者中医证型与西医肝衰竭分期之间的关系观察[J]. 诊断学理论与实践, 2021, 20(04): 391-395.
[11]	章淼滢, 罗飞宏. 儿童单基因糖尿病诊治进展及诊断策略[J]. 诊断学理论与实践, 2021, 20(03): 229-232.
[12]	芮文斌, 徐达, 祝宇, 吴瑜璇, 王浩飞, 汪成合, 袁菲. 缺氧诱导因子1α在乳头状肾细胞癌中的表达及其与预后的关系[J]. 诊断学理论与实践, 2021, 20(03): 265-370.
[13]	刘彤, 王鑫. 心房颤动预后不良风险的评估策略[J]. 诊断学理论与实践, 2020, 19(06): 555-558.
[14]	张中文, 左祥荣, 郑绪辉, 曹权, 李新立, 李艳秀. 3q26 rs12696304基因多态性与中国南方汉族老年人群急性心力衰竭患者一年预后间的关系研究[J]. 诊断学理论与实践, 2020, 19(06): 565-571.
[15]	杜海磊, 陈聆, 罗方秀, 李勇, 程齐俭, 朱良纲, 杭钧彪. Beclin-1和Bcl-2表达与非小细胞肺癌患者病理特征及预后间关系的研究[J]. 诊断学理论与实践, 2020, 19(03): 258-263.